Your session is about to expire
← Back to Search
dCBI for Inflammatory Bowel Disease
Study Summary
This trial will test a modified version of RxWell, which will include chronic disease management and transition readiness, to see if it is effective for patients ages 16-25.
- Inflammatory Bowel Disease
- Mental Health Issue
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this research program have an age limit?
"The age window for participants in this experiment is 16 to 25 years old."
Who meets the requirements to be a part of this research project?
"This clinical study is looking for 50 young patients that suffer from inflammatory bowel disease. Eligibility criteria include being between 16-25 years old, being treated at the UPMC Children's Hospital of Pittsburgh, speaking English, having a smartphone, and receiving a PHQ-4 score ≥ 5 and/or TRAQ score ≥ 60."
How many people are allowed to take part in this research project?
"That is correct. The information available on clinicaltrials.gov indicates that this trial has an open recruitment status. This study was first advertised on 7/30/2022 and received its most recent update on 8/9/2022. There is a total need for 50 individuals spread out over the course of 1 site."
Can people still sign up to participate in this research?
"This clinical trial is currently looking for participants, with the first posting on July 30th, 2020 and the most recent update being August 9th, 2020."
Share this study with friends
Copy Link
Messenger